StonvexLoading…
StonvexCore line items from LYB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-30 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $9.26B | $7.20B | $30.15B | $23.06B | $15.34B |
Operating Income | Not available | $239.00M | $-420.00M | $-332.00M | $399.00M |
Net Income | Not available | $125.00M | $-738.00M | $-598.00M | $292.00M |
EPS (Diluted) | $3.24 | $0.38 | $-2.34 | $-1.89 | $0.88 |
Total Assets | Not available | $33.96B | $34.00B | $33.79B | $35.35B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $2.63B | $3.44B | $1.78B | $1.70B |
Free Cash Flow OCF − CapEx | Not available | $-538.00M | $384.00M | $-673.00M | $-1.25B |
Shares Outstanding | Not available | 322.77M | 322.08M | 321.83M | 321.63M |